New Delhi
Biopharmaceutical major Pfizer India today announced that it has signed a Memorandum of Understanding (MoU) with Max Super Speciality Hospitals to give fellowships to young doctors at 17 Max Hospitals.
“This evidence generation will focus on prevention, treatment and management of diseases that are of public health priority in India, such as cancer and cardiovascular disease. The bespoke fellowships will be a form of recognition and will enable young clinicians who want to pursue medical research to do so with clear goals in place,” a joint statement mentioned.
Sonali Dighe, Senior Director Medical Affairs at Pfizer, said “We are very proud to partner with the Max chain of hospitals. This step is in line with our purpose to bring breakthroughs that change patients’ lives. Partnerships with eminent institutions such as Max chain of hospitals, with its large footprint across 17 hospitals in the country can help in this. Our partnership with Max will focus on capacity building initiatives including educational initiatives for HCPs and clinical research team in several therapy areas, such as oncology, cardiology, anti-microbial stewardship with and will include initiatives in women’s health, dermatology and vaccines.”